ClinicalThought

Share

Program Content

Activities

  • Patient Case: <i>MET</i>ex14+ NSCLC
    How I Am Using Selective MET Inhibitors in Patients With MET Exon 14–Positive NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 14, 2020

    Expires: August 13, 2021

Faculty

cover img faculity

Karen L. Reckamp, MD, MS

Associate Professor
Medical Oncology and Therapeutics Research
City of Hope Comprehensive Cancer Center
Duarte, California

Provided by

ProCE Banner

Supporters

Merck KGaA